Parkinson's Disease Trial, Recruiting NCT06074614 Sponsor: Radboud University Medical Center Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06074614
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Healthy volunteers who are adults (over 18 years old)
  • Adults with Parkinson's disease that has been confirmed by a specialist nerve doctor, with a disease severity rating between stages 1 and 3 on a standard scale (confirm with trial site, as the criteria contain a possible age note)
  • People who are willing and able to understand what the study involves
  • People who are able to take part and follow the study's requirements

Who may not be able to join:

  • Healthy volunteers who have had, or currently have, any condition affecting the brain or nervous system
  • Parkinson's patients who have, or have had, any other condition affecting the brain or nervous system (besides Parkinson's disease)
  • Anyone who has had, or is currently receiving, treatment for a psychiatric (mental health) condition
  • Anyone who has had brain surgery or epilepsy, including those who have a deep brain stimulation device
  • Anyone with a condition affecting the muscles or nerves that control them
  • Anyone with an existing lung condition, such as COPD, asthma, or pulmonary fibrosis
  • Anyone who cannot safely receive TMS (a type of brain stimulation), for example due to metal parts in the head or neck, or skin allergies
  • Anyone with an implanted heart pacemaker, defibrillator, nerve stimulator, cochlear implant, or medical pump device
  • Anyone with large or magnetic metal parts in the head (a dental wire is generally acceptable)
  • Anyone who is pregnant
  • Anyone who smokes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jonne Doorduin, PhD, Radboud University Medical Center

Phone: +31243611111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 October 2023
Est. completion
1 May 2025

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Hypercapnic ventilatory response curve; Respiratory related evoked potential; Transcranial magnetic stimulation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov